๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer

โœ Scribed by E.H Moase; W Qi; T Ishida; Z Gabos; B.M Longenecker; G.L Zimmermann; L Ding; M Krantz; T.M Allen

Book ID
117047740
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
328 KB
Volume
1510
Category
Article
ISSN
0005-2736

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Sterically stabilized anti-idiotype immu
Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model
โœ Yun-Long Tseng; Ruey-Long Hong; Mi-Hua Tao; Fu-Hsiung Chang ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 184 KB ๐Ÿ‘ 2 views

A liposome containing diverse synthetic lipid derivatives of polyethylene glycol (PEG) results in smaller distribution volume and longer circulation time in blood and, thus, may improve drug targeting. The characteristics and therapeutic efficacy of immunoliposomes with similar liposomal formulation

Sequential multiagent chemotherapy incor
Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer
โœ Richard L. Theriault; Gabriel N. Hortobagyi; Shu W. Kau; Frankie A. Holmes; Vere ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 567 KB

Forty-three consecutive patients with metastatic breast cancer and clearly measurable disease were treated with sequential multiagent chemotherapy. Therapy consisted of the administration in fixed sequence of cisplatin, doxorubicin, and cyclophosphamide (PAC) (four cycles), vinbbtine, doxorubicin, a